Prof. Dr. Helmut Friess

Academic Career and Research Areas

Professor Friess (b. 1962) has been the director of the Surgical Clinic and Policlinic at TUM’s Klinikum rechts der Isar since 2007. His research interests include the mechanisms of molecular development and the influence of growth factors on the aggressivity of pancreatic carcinoma. He has clarified many of the molecular signal pathways that contribute to the local infiltrative growth and metastasis of this extremely malignant tumor. In multiple surgical clinical trials he has examined various surgical techniques for resection of pancreatic tumors and leads multicenter studies on adjuvant therapies.

Professor Friess completed his medical degree at the University of Ulm and acquired his postdoctoral teaching qualification (habilitation) in 1998 at the University of Bern, Switzerland. Positions as a doctor and a scientist took him to the University of California at Irvine, USA (1992 – 1993), as an intern and later as a senior physician at the Inselspital of the University of Bern (1997 – 2001) and as a senior physician at the University Hospital in Heidelberg (2001 – 2007). Professor Friess is an honorary professor at the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the National Academy of Science of the Ukraine. Furthermore, he is a member of the General Assembly of the United European Gastroenterology Federation (UEGF), Secretary of the European Digestive Surgery (EDS) and formerly of the European Pancreatic Club (EPC).

Awards

  • Dr. Hella Bühler Prize, University of Heidelberg (2005)
  • Laureate of the Feldbausch Foundation, Heidelberg (2003)
  • Quality Promotion Award for Health, Baden-Württemberg (2002)
  • Surgical Research Prize, Swiss Society for Surgery, Switzerland (1996)

Friess H: „The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after”. Surgery. 2017; Band 161: 584-591.

Abstract

Friess H: „Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages”. PLoS medicine. 2010; Band 7: e1000267.

Abstract

Friess H: „Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial”. Jama. 2010; Band 304: 1073-1081.

Abstract

Friess H: „A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer”. New England Journal of Medicine. 2004; Band 350: 1200-1210.

Abstract

Friess H: „Acute necrotizing pancreatitis: treatment strategy according to the status of infection”. Annals of surgery. 2000; Band 232: 619.

Abstract